Status:
COMPLETED
Effects of Botulinum Toxin Type A in Adults With Cerebral Palsy
Lead Sponsor:
Sunnaas Rehabilitation Hospital
Collaborating Sponsors:
The Royal Norwegian Ministry of Health
Conditions:
Cerebral Palsy
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
The purpose of this project is to investigate if there is a significant difference in active joint range of motion, questionnaire on gait function and health related quality of life between patients r...
Detailed Description
Cerebral palsy (CP) is a constellation of symptoms and conditions defined as lifelong motor dysfunction resulting rom a non-progressive brain lesion occurring pre-, peri- or postnatal before the secon...
Eligibility Criteria
Inclusion
- Unilateral or bilateral spastic CP
- Modified Ashworth Scale (MAS) ≥ 2 in ankle- or knee joint muscles.
- ≥ 18 year of age, ≤ 65 year of age
- Ambulant without walking aids minimum 10 metres in functional equines and/or with pathological knee extension or flexion pattern.
Exclusion
- Cognitive impairment.
- No spasticity (MAS \< 2 )
- \< 18 year of age
- Not ambulant without walking aids
- Pregnant or planning pregnancy
- Btx-A treatment last 6 months
- Orthopedic surgery lower extremity last 18 months
- Obvious skeletal/joint deformity where orthopedic surgery is indicated
- Other diseases which can affect level of function (rheumatoid or neurological )
- New treatment the past four weeks which affect the musculoskeletal system (pain killers, physical therapy, acupuncture)
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2009
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT00432055
Start Date
January 1 2007
End Date
January 1 2009
Last Update
February 24 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sunnaas Rehabilitation Hospital
Bjoernemyr, Nesoddtangen, Norway, 1450